Key Highlights
- Dr. Tina S. Nova joins Truvian Health’s Board of Directors, adding over 20 years of biotech and diagnostics expertise.
- Former President and CEO of Decipher Biosciences, leading its $600M acquisition by Veracyte.
- Visionary leader in diagnostics innovation, with executive roles at Illumina, Genoptix, and Molecular Stethoscope.
Source: Business Wire
Notable Quotes
- “Truvian’s blood testing platform has the potential to revolutionize healthcare by giving patients more accurate and personalized lab results and treatment options.” – Dr. Tina S. Nova, Board Member at Truvian Health
- “Tina is a visionary leader who has deep knowledge of the clinical diagnostics industry scaling businesses from zero to one.” – Jay Srinivasan, CEO at Truvian Health
SoHC's Take
Dr. Tina S. Nova’s appointment to Truvian Health’s Board of Directors marks a significant milestone for the company as it continues to advance its mission of revolutionizing blood testing. Her proven track record of leading diagnostics companies through major acquisitions and IPOs will provide invaluable guidance as Truvian works toward regulatory approvals for its benchtop solution. With a focus on personalized medicine and accessible diagnostics, Truvian is poised to redefine healthcare delivery, making Dr. Nova’s leadership a crucial asset for the next phase of growth.
